- Home
- SSTI vs MCRB Comparison
SSTI vs MCRB Comparison
Compare SSTI & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSTI | MCRB |
|---|---|---|
| Founded | 1996 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.0M | 140.7M |
| IPO Year | 2017 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SSTI | MCRB |
|---|---|---|
| Price | $7.24 | $14.60 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $15.80 | $14.33 |
| AVG Volume (30 Days) | ★ 186.6K | 55.5K |
| Earning Date | 02-24-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | ★ $102,749,000.00 | $351,000.00 |
| Revenue This Year | $3.98 | N/A |
| Revenue Next Year | $9.86 | N/A |
| P/E Ratio | ★ N/A | $24.32 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.78 | $6.53 |
| 52 Week High | $19.43 | $29.98 |
Technical Indicators
Market Signals| Indicator | SSTI | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 38.30 | 43.97 |
| Support Level | $7.94 | $15.00 |
| Resistance Level | $8.83 | $16.42 |
| Average True Range (ATR) | 0.62 | 0.82 |
| MACD | -0.16 | 0.06 |
| Stochastic Oscillator | 16.90 | 25.00 |
Price Performance
Historical ComparisonAbout SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.